Literature DB >> 32305069

Protecting workers aged 60-69 years from COVID-19.

Judith R Glynn1.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32305069      PMCID: PMC7162642          DOI: 10.1016/S1473-3099(20)30311-X

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


× No keyword cloud information.
The initial estimates of the case fatality rate of coronavirus disease 2019 (COVID-19) from China and the published modelled estimates both show a very strong age-dependence.1, 2 In the UK, this pattern has been interpreted in public health terms as advice to cocoon (ie, isolate) those older than 70 years and those with underlying health conditions—but is this the right age cutoff? Applying the infection fatality rate ratios from new estimates (which assume a constant attack rate by age) to the age structure of the population of the UK, we can see how many deaths we would expect in each age group if there were 1 million infections (table ). This shows that 70% of all deaths are in the over-70-years age group, so it is important that they are protected. However, nearly two thirds (64%) of the remaining deaths occur in the 60–69 years age group. This age group is not being particularly protected and includes many who are working on the frontline. Indeed, health-care workers have even been encouraged to come out of retirement to assist.
Table

Estimated deaths by age group if 1 million people in the UK population are infected with SARS-CoV-2

Proportion of UK population (%)Infection fatality ratio (%)Number of deaths if 1 million population infectedProportion of deathsProportion of deaths if over 70s successfully cocooned
0–912%0·00161%2<1%<1%
10–1911%0·00695%8<1%<1%
20–2913%0·0309%41<1%1%
30–3913%0·0844%1121%3%
40–4913%0·161%2062%6%
50–5913%0·595%8038%25%
60–6911%1·93%205419%64%
70–798%4·28%353533%..
80+5%7·80%385336%..

Age group given in years. Infection fatality rates from Verity et al, and the population structure of the UK in 2018 from the Office for National Statistics. SARS-CoV-2=severe acute respiratory syndrome coronavirus 2.

Estimated deaths by age group if 1 million people in the UK population are infected with SARS-CoV-2 Age group given in years. Infection fatality rates from Verity et al, and the population structure of the UK in 2018 from the Office for National Statistics. SARS-CoV-2=severe acute respiratory syndrome coronavirus 2. Based on the Chinese data, each death corresponds to about two critical cases (needing intensive care) and six people who require hospitalisation. Both for humanitarian reasons and to prevent overload of the health service, shouldn't we be protecting people older than 60 years and ensuring that those in that age group who are currently not working from home are moved to jobs with minimal person contact, whether it is in the health service, schools, government, or the private sector?
  1 in total

1.  Estimates of the severity of coronavirus disease 2019: a model-based analysis.

Authors:  Robert Verity; Lucy C Okell; Ilaria Dorigatti; Peter Winskill; Charles Whittaker; Natsuko Imai; Gina Cuomo-Dannenburg; Hayley Thompson; Patrick G T Walker; Han Fu; Amy Dighe; Jamie T Griffin; Marc Baguelin; Sangeeta Bhatia; Adhiratha Boonyasiri; Anne Cori; Zulma Cucunubá; Rich FitzJohn; Katy Gaythorpe; Will Green; Arran Hamlet; Wes Hinsley; Daniel Laydon; Gemma Nedjati-Gilani; Steven Riley; Sabine van Elsland; Erik Volz; Haowei Wang; Yuanrong Wang; Xiaoyue Xi; Christl A Donnelly; Azra C Ghani; Neil M Ferguson
Journal:  Lancet Infect Dis       Date:  2020-03-30       Impact factor: 25.071

  1 in total
  9 in total

1.  The optimality of age-based lockdown policies.

Authors:  Raffaele Giammetti; Luca Papi; Désirée Teobaldelli; Davide Ticchi
Journal:  J Policy Model       Date:  2022-05-10

2.  COVID-19 in solid organ transplantation patients: A systematic review.

Authors:  Lucas Souto Nacif; Leonardo Y Zanini; Daniel R Waisberg; Rafael S Pinheiro; Flávio Galvão; Wellington Andraus; Luiz Carneiro D'Albuquerque
Journal:  Clinics (Sao Paulo)       Date:  2020-06-03       Impact factor: 2.365

Review 3.  Strategies for the practice of otolaryngology and head and neck surgery during the monitoring phase of COVID-19.

Authors:  Juan Manuel Maza-Solano; Guillermo Plaza-Mayor; Antonio Jiménez-Luna; Pablo Parente-Arias; Juan Carlos Amor-Dorado
Journal:  Acta Otorrinolaringol Esp (Engl Ed)       Date:  2020-05-25

4.  The role of weather conditions in COVID-19 transmission: A study of a global panel of 1236 regions.

Authors:  Chen Zhang; Hua Liao; Eric Strobl; Hui Li; Ru Li; Steen Solvang Jensen; Ying Zhang
Journal:  J Clean Prod       Date:  2021-01-16       Impact factor: 9.297

5.  Medical students' perceptions and motivations during the COVID-19 pandemic.

Authors:  Patricia Tempski; Fernanda M Arantes-Costa; Renata Kobayasi; Marina A M Siqueira; Matheus B Torsani; Bianca Q R C Amaro; Maria Eduarda F M Nascimento; Saulo L Siqueira; Itamar S Santos; Milton A Martins
Journal:  PLoS One       Date:  2021-03-17       Impact factor: 3.240

6.  Reduced mortality during the COVID-19 outbreak in Japan, 2020: a two-stage interrupted time-series design.

Authors:  Daisuke Onozuka; Yuta Tanoue; Shuhei Nomura; Takayuki Kawashima; Daisuke Yoneoka; Akifumi Eguchi; Chris Fook Sheng Ng; Kentaro Matsuura; Shoi Shi; Koji Makiyama; Shinya Uryu; Yumi Kawamura; Shinichi Takayanagi; Stuart Gilmour; Takehiko I Hayashi; Hiroaki Miyata; Francesco Sera; Tomimasa Sunagawa; Takuri Takahashi; Yuuki Tsuchihashi; Yusuke Kobayashi; Yuzo Arima; Kazuhiko Kanou; Motoi Suzuki; Masahiro Hashizume
Journal:  Int J Epidemiol       Date:  2022-02-18       Impact factor: 7.196

7.  First wave of SARS-COV2 in Europe: Study and typology of the 15 worst affected European countries.

Authors:  Alexandra Tragaki; Jean-Luc Richard
Journal:  Popul Space Place       Date:  2021-10-26

Review 8.  Rapid Review on COVID-19, Work-Related Aspects, and Age Differences.

Authors:  Lara Bellotti; Sara Zaniboni; Cristian Balducci; Gudela Grote
Journal:  Int J Environ Res Public Health       Date:  2021-05-13       Impact factor: 3.390

9.  COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience.

Authors:  Adrian M Shields; Siobhan O Burns; Sinisa Savic; Alex G Richter
Journal:  J Allergy Clin Immunol       Date:  2020-12-15       Impact factor: 14.290

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.